Dog Osteosarcoma: Palliative Care and Quality of Life

Osteosarcoma causes severe bone pain in large breed dogs. Palliative analgesia and informed quality-of-life assessment guides compassionate management decisions.

Key Facts

Osteosarcoma is the most common primary bone tumour in dogs, predominantly affecting giant breeds
Median survival without treatment is 1-4 months due to intractable pain
Amputation with chemotherapy extends median survival to 10-12 months in some cases
Palliative bisphosphonate and NSAID treatment reduces pain without surgical intervention
Radiation therapy provides palliative pain relief for 2-4 months in most cases

Welfare Considerations

Bone pain from osteosarcoma is severe and progressive — NSAIDs alone become insufficient as the disease advances. Multimodal palliative analgesia combining NSAIDs, gabapentin and opioids provides the best comfort management. Quality-of-life monitoring using validated tools helps owners and vets track the comfort-to-suffering balance and make timely euthanasia decisions. Dogs undergoing amputation often adapt remarkably well with appropriate rehabilitation. Owners need honest guidance about the disease trajectory and the welfare implications of both treatment and palliative care approaches.

What You Can Do

Request multimodal analgesia combining NSAIDs and gabapentin from the point of diagnosis
Monitor pain using validated canine pain scales and share findings with your vet regularly
Discuss amputation and chemotherapy suitability honestly given your dog age and fitness
Consider palliative radiation if amputation is not appropriate — it provides meaningful pain relief
Plan for timely euthanasia before severe breakthrough pain becomes unmanageable